Skip to main content
Fig. 6 | Journal of Nanobiotechnology

Fig. 6

From: Cartilage targeting therapy with reactive oxygen species-responsive nanocarrier for osteoarthritis

Fig. 6

MSN-OL alleviated the disease progression in rat OA model. A Representative images of H&E, safranin O/fast green and toluidine blue staining for each group at 12 weeks. B MicroCT 3D renderings of knee joints and subchondral bone at 12 weeks. C, D OARSI scores and total Mankin scores of articular cartilage. E The BV/TV analysis results of different groups. (* indicated p < 0.05, ** indicated p < 0.01, *** indicated p < 0.001 in comparison with OA or the OL treatment group, respectively)

Back to article page